Your session is about to expire
← Back to Search
SPARS Rehabilitation Program for Rotator Cuff Injury (SPARS-REHAB Trial)
N/A
Waitlist Available
Led By Helen Razmjou
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Planned conservative (non-operative) management
Diagnosed with rotator cuff tendinosis, shoulder impingement syndrome, or degenerative or traumatic rotator cuff tear
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
SPARS-REHAB Trial Summary
This trial will test whether the addition of SPARS to usual care can improve patient engagement with home physiotherapy and improve shoulder function compared to usual care alone.
Who is the study for?
This trial is for men and women over 18 who can do shoulder physiotherapy at home. They must have a rotator cuff injury like tendinosis, impingement syndrome, or a tear that's being treated without surgery. People with issues in the other shoulder, failed shoulder surgery, or nerve problems in the arm can't join.Check my eligibility
What is being tested?
The study tests a new system called SPARS that uses smartwatches and AI to track how well patients follow their home-based shoulder physiotherapy routines. It aims to see if this tech improves patient engagement and recovery from common shoulder injuries.See study design
What are the potential side effects?
Since SPARS involves non-invasive monitoring with wearable technology during physiotherapy exercises, side effects are minimal but may include skin irritation from the device or privacy concerns related to data collection.
SPARS-REHAB Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am planning to manage my condition without surgery.
Select...
I have been diagnosed with a shoulder condition or injury affecting the rotator cuff.
SPARS-REHAB Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Physiotherapy participation (Minutes weekly physiotherapy)
Secondary outcome measures
Numeric Pain Rating Scale (NPRS)
Shoulder active range of motion
Strength testing
+3 moreSPARS-REHAB Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: Injured Worker PopulationExperimental Treatment1 Intervention
Participants that have a confirmed rotator cuff pathology, and are undergoing physiotherapy at the Holland Centre for a work-related shoulder injury as part of the Working Condition Program.
Group II: Active Comparator: OHIP (funded) Patient PopulationActive Control1 Intervention
Participants that have a confirmed rotator cuff pathology, and are undergoing physiotherapy at the Holland Centre as part of the Shoulder Program.
Find a Location
Who is running the clinical trial?
Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,550,597 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,341 Previous Clinical Trials
26,452,688 Total Patients Enrolled
Helen RazmjouPrincipal InvestigatorSunnybrook Holland Orthopaedic & Arthritic Centre
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My other shoulder is painful and I can't move it well, needing treatment.I am over 18 years old.I am planning to manage my condition without surgery.I have been diagnosed with a shoulder condition or injury affecting the rotator cuff.I can do shoulder exercises at home.My shoulder surgery for a torn rotator cuff did not work.I have weakness or numbness in my arm or hand.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental: Injured Worker Population
- Group 2: Active Comparator: OHIP (funded) Patient Population
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining spots open for enrolment into this clinical research?
"Data on clinicaltrials.gov suggests that this medical trial, first made available on January 1st 2022 and last updated in December 2021, is no longer actively recruiting patients. Fortunately, the platform hosts two other studies presently searching for volunteers to participate."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger